Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Cipla
Federal Trade Commission
Cerilliant
Novartis
McKesson
Chubb
Accenture
Dow
McKinsey

Generated: January 19, 2018

DrugPatentWatch Database Preview

Cimetidine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cimetidine hydrochloride and what is the scope of cimetidine hydrochloride freedom to operate?

Cimetidine hydrochloride
is the generic ingredient in four branded drugs marketed by Dava Pharms Inc, Hospira, Luitpold, Teva Parenteral, Vintage Pharms Llc, Glaxosmithkline, Ani Pharms Inc, Apotex Inc, Cycle Pharms Ltd, G And W Labs Inc, Hi Tech Pharma, Pharm Assoc, and Wockhardt, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-five drug master file entries for cimetidine hydrochloride. One supplier is listed for this compound.
Pharmacology for cimetidine hydrochloride

US Patents and Regulatory Information for cimetidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride SOLUTION;ORAL 075560-001 Mar 15, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharm Assoc CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride SOLUTION;ORAL 074553-001 Jan 27, 1997 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cimetidine hydrochloride INJECTABLE;INJECTION 074468-003 Dec 29, 1994 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride INJECTABLE;INJECTION 074345-001 Jan 31, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride INJECTABLE;INJECTION 074296-001 Mar 28, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride INJECTABLE;INJECTION 074422-001 Jan 31, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cimetidine hydrochloride INJECTABLE;INJECTION 074468-004 Dec 29, 1994 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wockhardt CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride SOLUTION;ORAL 074757-001 Oct 17, 1997 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vintage Pharms Llc CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride SOLUTION;ORAL 074251-001 Dec 22, 1994 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride INJECTABLE;INJECTION 074412-001 Mar 28, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for cimetidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cimetidine hydrochloride INJECTABLE;INJECTION 019434-001 Oct 31, 1985 ➤ Subscribe ➤ Subscribe
Glaxosmithkline TAGAMET cimetidine hydrochloride INJECTABLE;INJECTION 017939-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Glaxosmithkline TAGAMET cimetidine hydrochloride INJECTABLE;INJECTION 017939-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Glaxosmithkline TAGAMET cimetidine hydrochloride SOLUTION;ORAL 017924-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Glaxosmithkline TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cimetidine hydrochloride INJECTABLE;INJECTION 019434-001 Oct 31, 1985 ➤ Subscribe ➤ Subscribe
Glaxosmithkline TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cimetidine hydrochloride INJECTABLE;INJECTION 019434-001 Oct 31, 1985 ➤ Subscribe ➤ Subscribe
Glaxosmithkline TAGAMET cimetidine hydrochloride SOLUTION;ORAL 017924-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Fuji
Covington
Medtronic
Cantor Fitzgerald
Merck
Healthtrust
Deloitte
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot